Davis Polk advised the representatives of the several underwriters in connection with the $240 million initial public offering of 12,650,000 shares of common stock of Olema Oncology at $19…
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a $307 million public offering of 4,150,000 shares of common stock…
Davis Polk advised Signify Health on its acquisition of PatientBlox. The acquisition accelerates Signify’s prospective provider payment capabilities for episodes of care, supporting the…
Davis Polk advised Antengene Corporation Limited in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering in reliance on Rule…
Davis Polk advised Auna S.A.A. in connection with its Rule 144A/Regulation S offering of $300 million aggregate principal amount of its 6.500% senior notes due 2025. The notes are…
Davis Polk advised the joint bookrunners on the equity offering of common shares of BK Brasil Operação e Assessoria a Restaurantes S.A. for an aggregate amount of approximately R$510…
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a $645.0 million public offering of 5,972,222 shares of common stock by…
Davis Polk advised the underwriters in connection with an SEC-registered offering by Norwegian Cruise Line Holdings Ltd. of 40,000,000 of its ordinary shares that raised approximately $824…
Davis Polk advised the representative of the several underwriters in connection with the SEC-registered offering of 38,000,000 shares of common stock of Plug Power Inc. for $845.5…
Davis Polk advised the sole book-running manager in connection with the $172.5 million initial public offering of 17,250,000 units of Population Health Investment Co., Inc., which includes…